These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 47343

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Prediction of the long-term results of antithyroid drug therapy for thyrotoxicosis.
    Alexander WD, McLarty DG, Robertson J, Shimmins J, Brownlie BE, Harden RM, Patel AR.
    J Clin Endocrinol Metab; 1970 Apr; 30(4):540-3. PubMed ID: 4190916
    [No Abstract] [Full Text] [Related]

  • 3. Thyroidal suppression by triiodothyronine as a guide to duration of treatment of thyrotoxicosis with antithyroid drugs.
    Alexander WD, Harden RM, Shimmins J.
    Lancet; 1966 Nov 12; 2(7472):1041-4. PubMed ID: 4162502
    [No Abstract] [Full Text] [Related]

  • 4. Treatment of thyrotoxicosis based on thyroidal suppressiblity.
    Alexander WD, Harden RM, Shimmins J, McLarty D, McGill P.
    Lancet; 1967 Sep 30; 2(7518):681-4. PubMed ID: 4167095
    [No Abstract] [Full Text] [Related]

  • 5. Evaluation of the triiodothyronine suppression test in the treatment of Graves' disease.
    Wils JA, Kloppenborg PW.
    Eur J Clin Invest; 1970 Aug 30; 1(2):90-3. PubMed ID: 4194884
    [No Abstract] [Full Text] [Related]

  • 6. Thyroidal suppressibility after stopping long-term treatment of thyrotoxicosis with anti-thyroid drugs.
    Alexander WD, Harden RM, McLarty D, Shimmins J.
    Metabolism; 1969 Jan 30; 18(1):58-62. PubMed ID: 4179400
    [No Abstract] [Full Text] [Related]

  • 7. Treatment of thyrotoxicosis with lithium carbonate.
    Lazarus JH, Richards AR, Addison GM, Owen GM.
    Lancet; 1974 Nov 16; 2(7890):1160-3. PubMed ID: 4139588
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Five-year follow-up of thyrotoxicosis treated with antithyroid drugs.
    Thalassinos NC, Oakley NW, Russell Fraser T.
    Endokrinologie; 1974 Sep 16; 63(3):325-30. PubMed ID: 4143392
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Drug treatment in thyroid disease.
    Mills LC.
    Semin Drug Treat; 1974 Sep 16; 3(4):377-402. PubMed ID: 4132535
    [No Abstract] [Full Text] [Related]

  • 12. Thyroid function after treatment of hyperthyroidism.
    Lancet; 1975 Sep 27; 2(7935):590-1. PubMed ID: 51412
    [No Abstract] [Full Text] [Related]

  • 13. Self-limiting episodes of recurrent thyrotoxicosis.
    McLarty DG, Alexander WD, Harden RM, Robertson JW.
    Lancet; 1971 Jan 02; 1(7688):6-9. PubMed ID: 4099357
    [No Abstract] [Full Text] [Related]

  • 14. [Long-term effects of anti-thyroid agents in thyrotoxicosis (author's transl)].
    Laroche C, Remy JM, Letellier P.
    Ann Endocrinol (Paris); 1974 Jan 02; 35(1):67-8. PubMed ID: 4138459
    [No Abstract] [Full Text] [Related]

  • 15. Thyroid suppression test as index of outcome of hyperthyroidism treated with antithyroid drugs.
    Cassidy CE.
    Metabolism; 1970 Oct 02; 19(10):745-50. PubMed ID: 4096944
    [No Abstract] [Full Text] [Related]

  • 16. Quantitative studies of iodine metabolism after long-term treatment of thyrotoxicosis with antithyroid drugs.
    Harden RM, Alexander WD, Koutras DA, Harrison MT, Wayne E.
    J Clin Endocrinol Metab; 1966 Apr 02; 26(4):397-401. PubMed ID: 4160410
    [No Abstract] [Full Text] [Related]

  • 17. Development of thyroidal suppression by triiodothyronine during six months' treatment of thyrotoxicosis with antithyroid drugs.
    Alexander WD, Harden RM, Shimmins J, McLarty D, McGill P.
    J Clin Endocrinol Metab; 1967 Dec 02; 27(12):1682-9. PubMed ID: 4168655
    [No Abstract] [Full Text] [Related]

  • 18. [Clinical studies on the thyroxine-binding capacity].
    Heki N.
    Nihon Naibunpi Gakkai Zasshi; 1968 Sep 20; 44(6):674-87. PubMed ID: 4179136
    [No Abstract] [Full Text] [Related]

  • 19. Prediction of the long-term results of antithyroid drug therapy for thyrotoxicosis.
    Hales I, Stiel J, Reeve T, Heap T, Myhill J.
    J Clin Endocrinol Metab; 1969 Jul 20; 29(7):998-1001. PubMed ID: 4183236
    [No Abstract] [Full Text] [Related]

  • 20. Antithyroid drug therapy in hyperthyroidism. Recurrence, hypothyroidism and thyroid antibodies.
    Stege R.
    Acta Chir Scand Suppl; 1980 Jul 20; 501():1-130. PubMed ID: 6163270
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.